|Articles|May 26, 2016
Challenges in 3D Bioprinting
Advertisement
Adam Feinberg, associate professor of Biomedical Engineering at Carnegie Mellon University, sat down with BioPharm International to discuss challenges in 3D bioprinting.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
5